MedTrace Logo

Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients

NCT03041051 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-02-02

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of a combined vaccination schedule of the 13-valent pneumococcal conjugate (PCV13) and 23valent plain polysaccharide vaccine (PPV23) on the establishment of immunological memory in HIV-infected adults on ART.

Conditions

  • HIV Infection

Interventions

BIOLOGICAL

PCV13

BIOLOGICAL

PPV23

Sponsors & Collaborators

  • Aghia Sophia Children's Hospital of Athens

    lead OTHER

Principal Investigators

  • Vana Spoulou · Greece 'Aghia Sophia' Children's Hospital Athens, Attiki, Greece, 11527

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-03-01
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03041051 on ClinicalTrials.gov